Laboratory diagnosis of Clostridium difficile infection in Spain: A population-based survey

Journal of Hospital Infection

Volumn 79, Issue 1, 2011, Pages 13-17

  Alcala L ^a,c,d   Marin M ^a,c,d   Martin A ^a   Sanchez Somolinos M ^a   Catalan P ^a   Pelaez M T ^a,b,c,d   Bouza, E ^a,b,c,d  

^a HOSPITAL GENERAL UNIVERSITARIO GREGORIO MARAÑÓN   (Spain)

^b UNIVERSIDAD COMPLUTENSE DE MADRID   (Spain)

^c Red Española de Investigación en Patología Infecciosa REIPI   (Spain)

^d INSTITUTO DE SALUD CARLOS III   (Spain)

Author keywords

Clostridium difficile; Diagnosis; Enzyme immunoassay; Incidence; Survey

Indexed keywords

ANTIBIOTIC AGENT; BACTERIAL TOXIN;

ANTIBIOTIC THERAPY; ARTICLE; BACTERIUM CULTURE; BACTERIUM DETECTION; BACTERIUM ISOLATE; CLOSTRIDIUM DIFFICILE; CLOSTRIDIUM DIFFICILE INFECTION; DIAGNOSTIC PROCEDURE; DIAGNOSTIC TEST; DIARRHEA; ENZYME IMMUNOASSAY; FECES ANALYSIS; HEALTH SURVEY; HOSPITAL ADMISSION; HOSPITAL INFECTION; HOSPITAL LABORATORY; HUMAN; INFECTION RATE; LABORATORY DIAGNOSIS; LOOSE FECES; SPAIN; TOXIN ANALYSIS;

CLINICAL LABORATORY TECHNIQUES; CLOSTRIDIUM DIFFICILE; DATA COLLECTION; ENTEROCOLITIS, PSEUDOMEMBRANOUS; HUMANS; IMMUNOENZYME TECHNIQUES; INCIDENCE; SPAIN;

EID: 80051472746     PISSN: 01956701     EISSN: 15322939     Source Type: Journal    
DOI: 10.1016/j.jhin.2011.05.017     Document Type: Article

References (20)

1. Bartlett J.G. Narrative review: the new epidemic of Clostridium difficile-associated enteric disease. Ann Intern Med 2006, 145:758-764.
2. Bartlett J.G. Clostridium difficile-associated enteric disease. Curr Infect Dis Rep 2002, 4:477-483.
3. Barbut F., Gariazzo B., Bonne L., et al. Clinical features of Clostridium difficile-associated infections and molecular characterization of strains: results of a retrospective study, 2000-2004. Infect Control Hosp Epidemiol 2007, 28:131-139.
4. Lyerly D.M., Krivan H.C., Wilkins T.D. Clostridium difficile: its disease and toxins. Clin Microbiol Rev 1988, 1:1-18.
5. Bouza E., Munoz P., Alonso R. Clinical manifestations, treatment and control of infections caused by Clostridium difficile. Clin Microbiol Infect 2005, 11(Suppl. 4):57-64.
6. Brazier J.S. The diagnosis of Clostridium difficile-associated disease. J Antimicrob Chemother 1998, 41(Suppl. C):29-40.
7. Laughon B.E., Viscidi R.P., Gdovin S.L., Yolken R.H., Bartlett J.G. Enzyme immunoassays for detection of Clostridium difficile toxins A and B in fecal specimens. J Infect Dis 1984, 149:781-788.
8. Sednaoui P., el Mantih B., Cauwell M. Pathol Biol (Paris) 1999, 47:415-421.
9. Bouza E., Pelaez T., Alonso R., Catalan P., Munoz P., Creixems M.R. " Second-look" cytotoxicity: an evaluation of culture plus cytotoxin assay of Clostridium difficile isolates in the laboratory diagnosis of CDAD. J Hosp Infect 2001, 48:233-237.
10. Delmee M. Laboratory diagnosis of Clostridium difficile disease. Clin Microbiol Infect 2001, 7:411-416.
11. Ticehurst J.R., Aird D.Z., Dam L.M., Borek A.P., Hargrove J.T., Carroll K.C. Effective detection of toxigenic Clostridium difficile by a two-step algorithm including tests for antigen and cytotoxin. J Clin Microbiol 2006, 44:1145-1149.
12. Zheng L., Keller S.F., Lyerly D.M., et al. Multicenter evaluation of a new screening test that detects Clostridium difficile in fecal specimens. J Clin Microbiol 2004, 42:3837-3840.
13. Liao Z., Lai D. Se Pu 1997, 15:216-218.
14. Barbut F., Delmee M., Brazier J.S., et al. A European survey of diagnostic methods and testing protocols for Clostridium difficile. Clin Microbiol Infect 2003, 9:989-996.
15. Fitzpatrick F., Oza A., Gilleece A., O'Byrne A.M., Drudy D. Laboratory diagnosis of Clostridium difficile-associated disease in the Republic of Ireland: a survey of Irish microbiology laboratories. J Hosp Infect 2008, 68:315-321.
16. Alfa M.J., Du T., Beda G. Survey of incidence of Clostridium difficile infection in Canadian hospitals and diagnostic approaches. J Clin Microbiol 1998, 36:2076-2080.
17. Karlstrom O., Fryklund B., Tullus K., Burman L.G. A prospective nationwide study of Clostridium difficile-associated diarrhea in Sweden. The Swedish C. difficile study group. Clin Infect Dis 1998, 26:141-145.
18. Alcala L., Marin M., Madrid M., et al. Comparison of ImmunoCard toxins A&B and the new semiautomated Vidas Clostridium difficile toxin A & B tests for diagnosis of C. difficile infection. J Clin Microbiol 2010, 48:1014-1015.
19. Alcala L., Sanchez-Cambronero L., Catalan M.P., et al. Comparison of three commercial methods for rapid detection of Clostridium difficile toxins A and B from fecal specimens. J Clin Microbiol 2008, 46:3833-3835.
20. Asensio A., Vaque-Rafart J., Calbo-Torrecillas F., et al. Increasing rates in Clostridium difficile infection (CDI) among hospitalised patients, Spain 1999-2007. Euro Surveill 2008, 13:18943.